Thrombotic microangiopathy after kidney transplantation.
about
Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipientDe novo glomerular diseases after renal transplantationAcute kidney injury in solid organ transplant recipients.Thrombotic thrombocytopenic purpura associated with everolimus use in a renal transplant patient.The role of endothelial cell injury in thrombotic microangiopathy.A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.Thrombotic microangiopathy after living-donor liver transplantation.An analysis of transplant glomerulopathy and thrombotic microangiopathy in kidney transplant biopsies.Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literatureAtypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case.The inferior impact of antibody-mediated rejection on the clinical outcome of kidney allografts that develop de novo thrombotic microangiopathy.De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.Differing tales of two patients after receiving a kidney transplant from a donor with disseminated intravascular coagulationIntracellular molecular effects of insulin resistance in patients with metabolic syndrome.Tacrolimus associated localized thrombotic microangiopathy developing in early stage after renal transplantationCharacteristics and Outcomes of Renal Transplant Recipients with Hemolytic Uremic Syndrome in the United States.Safety of mTOR inhibitors in adult solid organ transplantation.Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette.De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation.Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.Impact of treatment and outcomes for patients with posttransplant drug-associated thrombotic microangiopathy.Thrombotic Microangiopathy and the Kidney.Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab.Eculizumab for the treatment of atypical hemolytic uremic syndrome recurrence after kidney transplantation associated with complement factor H mutations: a case report with a 5-year follow-up.Effect of antihypertensive treatments on insulin signalling in lympho-monocytes of essential hypertensive patients: a pilot study.De Novo Atypical Haemolytic Uremic Syndrome after Kidney Transplantation.Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
P2860
Q24601710-FF166923-0FAA-4B66-A52A-6BC01C7A9F86Q27005877-9F5C5B42-A10D-465F-879A-AC31699F2FDFQ33378684-EAB04D20-3860-4B0B-9FDE-955B42AAD4F0Q33389749-BFB738AD-A695-4F05-AAD5-686798257EFEQ33391882-47A4F8B9-A8E0-43A0-96E8-A6BED4873C17Q33395560-7AAAB17C-FC49-49C9-9CCB-60F0A5D87496Q33398129-561A722B-A770-4287-BFAB-0A3F0F54AD7FQ33414342-4EF1DD05-F3D3-4ED9-B710-B9ADCD129087Q33421909-649C2623-AAA1-47FE-AB21-87AA4F464E2FQ33423267-32056B92-9E87-430E-B179-C64C0392F235Q33424525-3F9DCCE0-1E06-45BB-81C1-0FAC9822E127Q33426548-1CEB18EC-BB6D-44F0-936B-81E70D928057Q33439133-29614FC6-D1D6-41C6-90B9-195B0DCC2FF0Q33908301-379817EC-7A45-4B2D-9403-1EC6CEDA6A4FQ34133898-C938DC1B-5456-4777-B048-A27CD0238AD2Q36554196-86B7DD3E-84EA-4963-87FE-24A4EEF78AC4Q36641955-35009986-DDF6-4EBE-9A5F-5CE6ADBAC115Q38669190-A0BA9B8C-9E22-418C-84E3-B834A4AE476DQ40426421-C2405E68-BA4A-4A3C-B062-2B76D378C35BQ41019245-71FB5474-0651-4167-AB96-F3A755799E31Q42086661-BA3EC0DB-98CA-4C51-902B-B882ECD91AA9Q47912606-621C5AE0-6978-4C1B-B8C6-72D69E03C7CEQ50085453-CB6566A2-106A-407C-BB89-BA7C3E464D8FQ51333222-397BC460-71F0-4280-B6E0-F7416F17A5C8Q53180638-245FFB48-4235-451D-BD57-F4FEAF3EA29FQ54355912-D1EA1523-DB51-413F-B123-65106D3947AAQ55128066-516D8E90-904D-4898-8A4C-7A6670EB5F30Q57151742-79A6E886-2352-449E-BB4D-18E4EABD4562
P2860
Thrombotic microangiopathy after kidney transplantation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Thrombotic microangiopathy after kidney transplantation.
@ast
Thrombotic microangiopathy after kidney transplantation.
@en
type
label
Thrombotic microangiopathy after kidney transplantation.
@ast
Thrombotic microangiopathy after kidney transplantation.
@en
prefLabel
Thrombotic microangiopathy after kidney transplantation.
@ast
Thrombotic microangiopathy after kidney transplantation.
@en
P2860
P1476
Thrombotic microangiopathy after kidney transplantation.
@en
P2093
Claudio Ponticelli
Giovanni Banfi
P2860
P304
P356
10.1111/J.1432-2277.2006.00354.X
P577
2006-10-01T00:00:00Z